Webinar

Drug Pricing in Canada: Navigating Potential U.S. MFN Implications

Life Sciences Group Webinar
When (ET)
Share

Overview

As the United States moves towards an international reference pricing model in an effort to reduce prescription drug costs, questions arise regarding the potential impacts on drug pricing and marketing in OECD reference countries.

This important webinar will provide an overview of the Most Favored Nation (MFN) GLOBE and GUARD pricing models proposed by the Trump administration in December 2025 and address potential Canada specific concerns.

The panel will include perspectives from leading Canadian and US drug pricing lawyers, Canadian health policy experts (including the former Executive Director of the PMPRB and VP of CADTH), and the Ontario Ministry of Health.

The session will be moderated by The Honourable Christine Elliott, former Ontario Minister of Health and Deputy Premier.

Speakers 

  • Margaux Hall, Partner, Healthcare – Ropes & Gray, Washington, DC
  • Wayne Critchley, Senior Associate – Global Public Affairs (Former Executive Director of the PMPRB and Vice President of the Canadian Agency for Drugs and Technologies in Health)
  • Patrick Dicerni, Assistant Deputy Minister of the Health Programs and Delivery Division and Executive Officer, Ontario Public Drug Programs, at the Ontario Ministry of Health
  • Timothy Squire, Partner, Co-Leader, Life Sciences Industry Group, Fasken
  • Ingrid VanderElst, Partner, Life Sciences Industry Group, Fasken
  • Christine Elliott, Counsel, Health Law Group, Fasken and former Ontario Minister of Health and Deputy Premier (Moderator) 

Agenda

  • 12:00 pm - 1:30 pm ET Webinar and Q&A
  • 9:00 am - 10:30 am PT
  • 10:00 am - 11:30 am MT

Cost

This webinar is complimentary 

1.5Hours Available Via Webinar
This program is eligible for up to 1.5 Substantive Hours with the Law Society of Ontario.

This program contains 1.5 hours of accredited content for the purposes of the Law Society of British Columbia’s annual Continuing Professional Development (CPD) requirements. The session has been loaded with the LSBC and is titled "Drug Pricing in Canada: Navigating Potential U.S. MFN Implications - February 6, 2026”. It is available for claiming through your LSBC Member Portal.

A confirmation of participation will be sent to you for your continuing education hours with the Barreau du Québec.

For CPD/CLE in other jurisdictions, please contact your local Law Society.

Event Contact

Andrea Tulloch Marketing Events Manager +1 416 868 3329

Speakers

  • Timothy M. Squire, Partner | CO-LEADER, LIFE SCIENCES, Toronto, ON, +1 416 868 3462, [email protected]
  • Ingrid E. VanderElst, PhD, Partner | Trademark Agent | Intellectual Property, Toronto, ON, +1 416 865 4519, [email protected]
  • Christine Elliott, KC, Counsel | Health, Toronto, ON, +1 416 865 5436, [email protected]
Timothy Squire Toronto Lawyer Timothy M. Squire Partner | CO-LEADER, LIFE SCIENCES Toronto, ON +1 416 868 3462
Ingrid Vanderelst Toronto Lawyer Ingrid E. VanderElst, PhD Partner | Trademark Agent | Intellectual Property Toronto, ON +1 416 865 4519
Christine Elliott Toronto Counsel Christine Elliott, KC Counsel | Health Toronto, ON +1 416 865 5436

    You might be interested in...

    • Canada-Trump Administration 2.0, As Canadian businesses and governments digest and consider the implications of the 2nd Trump Administration, Fasken is leading in its efforts to support our clients and Canadian businesses through the risks and disruptions of political and economic uncertainty.
    Ottawa Landscape Knowledge Centre Canada-Trump Administration 2.0 As Canadian businesses and governments digest and consider the implications of the 2nd Trump Administration, Fasken is leading in its efforts to support our clients and Canadian businesses through the risks and disruptions of political and economic uncertainty. Read more